Eli Lilly crashes out of KRAS race as toxicity sees it ditch phase 1 effort

Eli Lilly crashes out of KRAS race as toxicity sees it ditch phase 1 effort

Submitted by admin on July 30, 2020 - 11:11am
Source: 
Fierce Biotech
News Tags: 
Eli Lilly
KRAS inhibitors
cancer
Headline: 
Eli Lilly crashes out of KRAS race as toxicity sees it ditch phase 1 effort
snippet: 

Eli Lilly has quietly dropped its KRAS effort in cancer, leaving the door open for its rivals.

Do Not Allow Advertisers to Use My Personal information